Academics from Emory University in Atlanta have found that GLP-1 RAs significantly protect people with type 2 diabetes and ...

Vistin Pharma ASA ( ($DE:VP4) ) has issued an update. Vistin Pharma ASA reported a revenue increase in the third quarter of 2025, driven by a 10% ...

People develop type 2 diabetes for a combination of reasons, like a sedentary lifestyle and an unhealthy diet, but genetics ...

A gene on the X chromosome revs up inflammation in the female brain, which may explain why rates of multiple sclerosis are ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Deborah J. Wexler, MD, MSc, and colleagues reviewed recent shifts in diabetes care, such as SGLT2i and GLP-1 RA medications.

A new study published in the journal BMC Medicine showed that sitagliptin treatment helped preserve total femur T scores in ...

Germany sold more than 15 million tonnes of pharmaceutical products to China in 2024, while China sold more than 33 million ...

Pre-diabetes offers a crucial chance to reset metabolism and prevent full diabetes. Longevity doctor Dr. Vassily Eliopoulos ...

Heald, the human-led, tech-enabled platform redefining Diabetes care, proudly announces that Dr. Sunita Mishra, former Chief ...

Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with ...